|
HS Code |
673948 |
| Iupac Name | diethyl 4-(2-bromophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
| Molecular Formula | C20H22BrNO4 |
| Molecular Weight | 420.3 g/mol |
| Cas Number | 85799-63-9 |
| Appearance | Yellow powder |
| Melting Point | 170-172°C |
| Solubility | Soluble in organic solvents such as chloroform and dichloromethane |
| Boiling Point | Decomposes before boiling |
| Purity | Typically ≥98% |
| Smiles | CCOC(=O)C1=C(C)NC(C)=C(C(=C1)C2=CC=CC=C2Br)C(=O)OCC |
As an accredited 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The product is supplied in a 25-gram amber glass bottle with a secure screw cap and clearly labeled with chemical identification. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with securely packed drums of 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester. |
| Shipping | The chemical 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester is shipped in tightly sealed containers under ambient conditions. It is protected from light, moisture, and excessive heat. All packages are clearly labeled and comply with applicable regulations for handling and transport of potentially hazardous materials. |
| Storage | Store 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester in a tightly sealed container, away from light, moisture, and incompatible substances such as oxidizers. Keep at room temperature in a cool, dry, and well-ventilated area. Avoid direct sunlight and sources of ignition. Ensure proper labeling and access only to trained personnel. Use appropriate protective equipment when handling. |
| Shelf Life | Shelf life: Stable for at least 2 years when stored in a cool, dry place, protected from light and moisture. |
|
Purity 98%: 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester with a purity of 98% is used in pharmaceutical intermediate synthesis, where it ensures optimal reaction yield and product uniformity. Melting point 105°C: 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester featuring a melting point of 105°C is used in solid-state formulation development, where it provides predictable thermal processing behavior. Molecular weight 454.33 g/mol: 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester with a molecular weight of 454.33 g/mol is used in drug design research, where it allows precise molecular modeling and dose calculation. Stability at 60°C: 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester demonstrating stability at 60°C is used in accelerated aging studies, where it supports evaluation of shelf life and storage requirements. Particle size <10 μm: 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester with particle size below 10 μm is used in fine chemical manufacturing, where it enhances dissolution rates and processing efficiency. |
Competitive 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester stands as a testament to how expertise and technical application meet growing demand in active pharmaceutical ingredients and research intermediates. In our experience, clients face real hurdles sourcing molecules with reliable purity and consistent physical characteristics. The slightest deviation in quality can disrupt downstream synthesis, waste valuable resource, or skew research data.
The practical story behind making this compound starts with an understanding of its structural backbone. As a manufacturer, our teams recognize that maintaining the bromophenyl moiety intact through controlled nitration, halogenation, and esterification requires both optimized reaction conditions and vigilance against undesired side products. Over the years, we have refined our processes, minimizing residual moisture and reducing unwanted bromine exchange. Each batch arrives after monitored crystallization and drying, since customers cite challenges if even trace impurities or solvent residues persist.
When supplying 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester, exactness in specification makes all the difference. Our standard workflow uses NMR, GC-MS, and HPLC analysis to ensure high purity, often exceeding 98%. Consistent particle sizing helps researchers and formulators avoid difficulties observed with irregular granulation, such as poor dispersibility or measuring errors in the lab. The color of finished product and melting point give additional confidence to users, especially within established research or scale-up routines.
We have seen poorly controlled specifications—whether from hastily sourced intermediates or trading channels—cause costly stoppages in multi-step syntheses. The attention paid to water, halide, and heavy metal content maintains the trust our customers place in our product lines. Years back, feedback prompted us to upgrade purification systems, reducing by-products like methyl ethyl ketone or trace unreacted acid. These technical improvements often start from a single client’s trouble on their production line and become revised protocols across our factory.
Looking at usage, this compound steps into varied roles—each demanding different levels of documentation, clarity, and support. Primary fields include pharmaceutical development, medicinal chemistry research, and agrochemical evaluation. We work with academic and biotech customers who use this molecule as a key building block when creating candidate drugs with calcium channel modulating profiles. Its ester groups demark it from more volatile acid derivatives, enabling smoother incorporation into synthetic schemes and increasing compatibility with organic solvents.
Recent years have brought a rise in requests for custom batch sizes and packaging, partly reflecting the increasingly specialized directions in synthetic and discovery labs. Early-stage researchers might request tens of grams, while process chemists scaling up need ten or a hundred times that amount. Feedback from pilot facilities led us to refine bulk packaging, helping minimize contamination risk and product loss during weighing.
Some clients operate in regulated environments, requesting full traceability from raw material supply through to bottle sealing, and our in-house procedures grew up to support those needs. Our batch records, pre-shipment certifications, and compliance reporting resulted from working side-by-side with QA teams facing evolving expectations. A few years ago, an international partner’s need for REACH and RoHS-instructed formulations drove our early compliance with trace element control and shipment tracking systems.
For formulators and researchers, differences between 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester and its near neighbors are more than academic. Unlike its methyl ester counterparts or the unsubstituted pyridine skeletons, this specific structure demonstrates increased solubility in a range of alcohols and ether-type solvents. Where competitors’ products sometimes settle out of solution unpredictably, our clients report consistent dissolution, even in concentrated stock solutions.
The bromo group on the phenyl ring sets this compound apart in terms of reactivity. Our experience shows it not only modulates selectivity in coupling reactions but offers additional synthetic entry points, which unlock derivative classes of compounds in discovery chemistry. Requests often come from research projects seeking substitution patterns not possible with plain phenyl analogues, and we’ve supported their work with tailored advice based on lab data.
Field reports from customers often highlight fewer batch-to-batch variations as a major differentiation point. Competing products, often brokered and repackaged through multiple entities, pick up minor contaminations or storage instabilities. We maintain storage conditions below recommendations for photo- and thermal-sensitivity, based on incidents reported industry-wide involving similar diethyl esters developing trace decomposition. For formulations requiring additional stabilizers or inert gas packing, we adapt based on direct user feedback.
This compound’s ability to support both established synthesis and new reaction exploration drives ongoing investment in its robust production. We collaborate with university chemists looking for unique calcium channel modulating backbones, as well as custom synthesis houses requiring extra documentation and detailed methods sections for regulatory submissions. We’ve helped teams troubleshoot unexpected LC-MS peaks, isolate side-products for structural determination, and even redesign purification routes to maximize usable yield from restricted starting materials.
Recent conversations with pharmaceutical clients have opened avenues for green chemistry integration. Substituting greener solvents during purification required substantial process adaptation, but gave downstream users opportunities to gain support for their sustainability audits. In one challenge, a partner sought route optimization that avoided halogenated solvents entirely. Drawing on solvent selection guides and pilot-scale testing, our staff identified ethyl acetate and alcohol blends that maintained product stability without sacrificing clarity or recovery yield.
Process documentation remains a living record. Requests for specific forms—crystalline or amorphous—or particular moisture ranges sometimes arise based on application. Whether a customer needs rapid redissolution or lower hygroscopicity for shipping, our R&D team responds with adjustments in final drying or anti-clumping measures, sharing internal process improvements when clients confront unforeseen bottlenecks during transfer from research to pilot plant.
The ongoing exchange of data, troubleshooting, and on-the-ground needs from chemists using this pyridinedicarboxylic acid ester accelerates our own development pace. We’ve witnessed how even trace changes in impurity profile can derail a quantitative NMR spectrum or complicate a scale-up transfer. After observing multiple cases where off-the-shelf supply introduced too much batch-to-batch drift, our teams sharpened raw material input selection, stepped up line monitoring, and overhauled post-crystallization quality checks.
Sharing technician notes, chromatogram profiles, and even anecdotal observations with users forms a cycle of feedback that fine-tunes the manufacture. For example, a pharmaceutical partner in quality control flagged unexpected UV-Vis absorption in several shipments. Investigation revealed a trace by-product formed during extended storage in mixed humidity, leading us to redesign both packaging and the post-purification drying cycle. These collaborative improvements ripple outward—from our next production run through to how distributors store inventory and even how researchers design future experiments downstream.
Direct manufacturing relationships reduce confusion—something that becomes critical with complex intermediates such as 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester. Discussions with scientists, procurement managers, and process engineers center on batch traceability, supply consistency, and evidence supporting every technical claim. We believe that hands-on production and documentation create the clearest platform for problem-solving, whether in synthetic troubleshooting, impurity tracking, or planning future projects.
Uncertainties multiply each time molecules transit from one trader to the next. We’ve supported research teams stymied by mysterious inactivity in their chemistry, later traced to mislabeled or blended esters bought through indirect channels. This lesson reinforced our commitment to supply the chemical straight from our own controlled processes, with QC and traceability records always accessible. The fine points—such as a two-degree variation in melting point, or a chromatogram peak just above accepted impurity limits—must receive direct technical attention. Relying on firsthand knowledge, not hearsay, makes the difference between successful research and costly reruns.
Keeping pace with regulatory changes shaped a big part of how we operate. Many of our customers now require regulatory support for their filings, including details on origin, content, residual solvents, and impurity control. We respond by maintaining up-to-date documentation on any reagent or auxiliary that touches the compound, including those that remain in trace.
A few years ago, adjusting product lines for REACH and other chemical inventory regimes forced deep dives into upstream raw materials and supplier relationships. We only select reagents with robust analytical backing. Environmental moves, such as restrictions on halogenated waste or solvent emissions, prompted further process overhauls. For some chemicals, trade-offs related to waste minimization or energy use challenged the very routines that had run for years. But broad adoption of solvent recovery, purification column recycling, and in-process monitoring helped to control both cost pressures and environmental risks.
We noticed, especially with this family of pyridinedicarboxylic acid esters, that documentation requirements keep evolving: NMR spectra, FTIR data, and full elemental analysis are now often expected by default. By integrating these into batch certification, we spare our customers last-minute hassles during internal or external audits.
Translating processes from lab bench to factory scale delivers a long list of technical and logistical hurdles. We recall projects years ago where hundreds of grams of product delivered by small-scale glass reactors couldn’t directly translate to steel vessels. Differences in agitation, cooling, and even stirrer geometry all mattered. With 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester, meticulous control over addition rates and reaction temperature provide the cornerstone for batch integrity.
Drainage profiles, filtration methods, and solvent swap techniques each influence yield and product attributes. On more than one occasion, floor operators caught subtle color or odor changes indicating minor deviations, and quick interventions prevented off-spec material from being packaged. Feedback from customers performing their own scale-up inspired us to publish detailed procedural notes, moving beyond minimal disclosures to include tips and risk alerts learned from years of trouble-shooting at volume.
Wastage reduction, by-product collection, and batch yield maximization all become far more important as production moves upwards. Adapting to each project’s unique risk points—storage temp, humidity, oxygen level—keeps material quality on track, since the downstream impacts of a flawed batch multiply with each scale jump.
Interest in 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester keeps rising, not just in traditional drug discovery avenues but also in emerging material science and specialty chemical applications. Early conversations with electronics and polymer additive groups point toward new areas for targeted functionalization, where the unique substitution pattern presents custom electronic or binding characteristics.
Feedback-driven R&D partnerships allow new synthesis approaches to take off faster. Our in-house chemists regularly explore routes to shorten reaction times, boost atom economy, and open up previously-inaccessible derivatives. Direct input from end-users, combined with real-world trial data, keeps us alert to market transitions—whether a customer switches from a methyl to an ethyl ester, or changes solvent systems for greener operations. Taking practical lessons from each feedback round, we refine product lines for reliability, clarity, and relevance.
Today’s research world expects manufacturers to provide more than just product—they expect technical partnership. Our lines stay open for both incremental troubleshooting and ambitious application development. This approach, shaped by ongoing interactions and problem-solving, forms the foundation of our business model, supporting research, scale-up, and full industrial production runs.
Organizations depend on reliable, authentic sources for core intermediates. Over time, we have learned that hands-on manufacturing leads to better, more predictable outcomes. Customers want straight answers and timely technical support. Each request for “can you supply…” sparks planning—checking raw material inventories, assessing process capacity, and pulling up archived production notes for similar projects.
Direct lines between producer and user translate to actionable improvements. Our relationships often begin with a formulation headache or an unanticipated analytical issue. We urge prospective partners to seek not only documentation, but also real working experience behind a chemical supply.
Manufacturing 4-(2-Bromophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid diethyl ester brings daily evidence that technical depth, responsiveness, and dialogue mark the difference between an intermediate that solves problems and one that introduces them. We value every update on how our compounds fare in diverse situations, knowing that collective experience shapes tomorrow’s innovations and set standards for chemical supply.